Allspring Global Investments’s Avanos Medical AVNS Stock Holding History

Allspring Global Investments’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-2,636	Closed	-$53.3K	–	2256
2023 Q3	$53.3K	Sell	2,636 -56,209	-96%	-$1.27M	﹤0.01%	2241
2023 Q2	$1.5M	Buy	58,845 +5,146	+10%	+$136K	﹤0.01%	1317
2023 Q1	$1.6M	Sell	53,699 -1,374	-2%	-$39.9K	﹤0.01%	1315
2022 Q4	$1.49M	Buy	55,073 +50,554	+1,119%	+$1.24M	﹤0.01%	1327
2022 Q3	$98K	Buy	4,519 +2,213	+96%	+$57.8K	﹤0.01%	2088
2022 Q2	$63K	Sell	2,306 -17,986	-89%	-$517K	﹤0.01%	2190
2022 Q1	$679K	Sell	20,292 -108	-0.5%	-$3.48K	﹤0.01%	2094
2021 Q4	$707K	Buy	+20,400	New	+$660K	﹤0.01%	2140

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

WHG

Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Allspring Global Investments's AVNS Position: Q4 2023 in Review

Allspring Global Investments sold out of Avanos Medical (AVNS) in Q4 2023, closing a stake of 2,636 shares — an estimated $53.3K sold.

Allspring Global Investments first reported a position in AVNS in Q4 2021 and held it in 8 quarters. The position peaked at $1.6M in Q1 2023. 265 funds tracked by Wall St. Rank hold AVNS as of Q4 2023.

Allspring Global Investments reported no remaining Avanos Medical position as of Q4 2023 after selling out during the quarter.
Allspring Global Investments sold 2,636 Avanos Medical shares in Q4 2023, an estimated $53.3K.
Allspring Global Investments first reported a position in Avanos Medical in Q4 2021 and held it in 8 quarters.
Allspring Global Investments's Avanos Medical position peaked at $1.6M in Q1 2023.
265 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2023.

Based on Allspring Global Investments's 13F filing for Q4 2023, filed 25 Jan 2024.